AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 259: E822-E827, 1990;
0193-1849/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bechet, D. M.
Right arrow Articles by Quirke, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bechet, D. M.
Right arrow Articles by Quirke, J. F.

AJP - Endocrinology and Metabolism, Vol 259, Issue 6 E822-E827, Copyright © 1990 by American Physiological Society


ARTICLES

Cimaterol reduces cathepsin activities but has no anabolic effect in cultured myotubes

D. M. Bechet, A. Listrat, C. Deval, M. Ferrara and J. F. Quirke
Unite de Recherche sur l'Expression des Proteases, Institut National De La Recherche Agronomique, Ceyrat, France.

The effect of the beta-adrenergic agonist cimaterol on bovine and chicken primary myotubes was assessed. Cimaterol at 10-100 nM concentrations reduced cathepsin B benzyloxy-carbonyl-Arg-Arg-4-methyl-7-coumarylamide hydrolyzing activity, as well as benzyloxycarbonyl-Phe-Arg-4-methyl-7-coumarylamide hydrolysis, which is a substrate for both cathepsin B and cathepsin L. Maximum effect was observed after 6-16 h treatment. Cathepsin H Arg-4-methyl-7-coumarylamide hydrolyzing activity was low and not significantly affected by cimaterol treatment. Despite decreasing cathepsin activities, cimaterol also increased proteolysis rates but induced no detectable effect on protein synthesis rates. These observations suggest that beta-agonists, as a result of a direct action on muscle, can decrease cathepsin activities but that beta-agonist-induced muscle hypertrophy may not be due to a direct effect on muscle cells.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. C. C. Navegantes, N. M. Z. Resano, A. M. Baviera, R. H. Migliorini, and I. C. Kettelhut
Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E642 - E647.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. C. C. Navegantes, N. M. Z. Resano, R. H. Migliorini, and I. C. Kettelhut
Catecholamines inhibit Ca2+-dependent proteolysis in rat skeletal muscle through {beta}2-adrenoceptors and cAMP
Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E449 - E454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online